277 related articles for article (PubMed ID: 22777354)
1. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
Scribner KC; Behbod F; Porter WW
Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
[TBL] [Abstract][Full Text] [Related]
2. Loss of singleminded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of slug and matrix metalloprotease 2.
Laffin B; Wellberg E; Kwak HI; Burghardt RC; Metz RP; Gustafson T; Schedin P; Porter WW
Mol Cell Biol; 2008 Mar; 28(6):1936-46. PubMed ID: 18160708
[TBL] [Abstract][Full Text] [Related]
3. The bHLH/PAS transcription factor singleminded 2s promotes mammary gland lactogenic differentiation.
Wellberg E; Metz RP; Parker C; Porter WW
Development; 2010 Mar; 137(6):945-52. PubMed ID: 20150276
[TBL] [Abstract][Full Text] [Related]
4. Singleminded-2s (Sim2s) promotes delayed involution of the mouse mammary gland through suppression of Stat3 and NFκB.
Scribner KC; Wellberg EA; Metz RP; Porter WW
Mol Endocrinol; 2011 Apr; 25(4):635-44. PubMed ID: 21292822
[TBL] [Abstract][Full Text] [Related]
5. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between SIM2s and NFκB regulates cyclooxygenase 2 expression in breast cancer.
Wyatt GL; Crump LS; Young CM; Wessells VM; McQueen CM; Wall SW; Gustafson TL; Fan YY; Chapkin RS; Porter WW; Lyons TR
Breast Cancer Res; 2019 Nov; 21(1):131. PubMed ID: 31783895
[TBL] [Abstract][Full Text] [Related]
7. Ha-Ras transformation of MCF10A cells leads to repression of Singleminded-2s through NOTCH and C/EBPbeta.
Gustafson TL; Wellberg E; Laffin B; Schilling L; Metz RP; Zahnow CA; Porter WW
Oncogene; 2009 Mar; 28(12):1561-8. PubMed ID: 19169276
[TBL] [Abstract][Full Text] [Related]
8. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
[TBL] [Abstract][Full Text] [Related]
9. ATM-dependent activation of SIM2s regulates homologous recombination and epithelial-mesenchymal transition.
Pearson SJ; Roy Sarkar T; McQueen CM; Elswood J; Schmitt EE; Wall SW; Scribner KC; Wyatt G; Barhoumi R; Behbod F; Rijnkels M; Porter WW
Oncogene; 2019 Apr; 38(14):2611-2626. PubMed ID: 30531838
[TBL] [Abstract][Full Text] [Related]
10. Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup.
Shekhar MP; Kato I; Nangia-Makker P; Tait L
Oncotarget; 2013 Feb; 4(2):231-41. PubMed ID: 23548208
[TBL] [Abstract][Full Text] [Related]
11. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.
Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ
Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma
Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q
J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126
[TBL] [Abstract][Full Text] [Related]
13. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.
Lee S; Stewart S; Nagtegaal I; Luo J; Wu Y; Colditz G; Medina D; Allred DC
Cancer Res; 2012 Sep; 72(17):4574-86. PubMed ID: 22751464
[TBL] [Abstract][Full Text] [Related]
14. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
[TBL] [Abstract][Full Text] [Related]
15. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
Megha T; Ferrari F; Benvenuto A; Bellan C; Lalinga AV; Lazzi S; Bartolommei S; Cevenini G; Leoncini L; Tosi P
J Clin Pathol; 2002 Jun; 55(6):461-6. PubMed ID: 12037031
[TBL] [Abstract][Full Text] [Related]
16. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
[TBL] [Abstract][Full Text] [Related]
17. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
[TBL] [Abstract][Full Text] [Related]
18. TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.
Krstic M; Kolendowski B; Cecchini MJ; Postenka CO; Hassan HM; Andrews J; MacMillan CD; Williams KC; Leong HS; Brackstone M; Torchia J; Chambers AF; Tuck AB
J Pathol; 2019 Jun; 248(2):191-203. PubMed ID: 30697731
[TBL] [Abstract][Full Text] [Related]
19. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.
Casbas-Hernandez P; D'Arcy M; Roman-Perez E; Brauer HA; McNaughton K; Miller SM; Chhetri RK; Oldenburg AL; Fleming JM; Amos KD; Makowski L; Troester MA
Breast Cancer Res; 2013; 15(5):R82. PubMed ID: 24025166
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma
Shan NL; Minden A; Furmanski P; Bak MJ; Cai L; Wernyj R; Sargsyan D; Cheng D; Wu R; Kuo HD; Li SN; Fang M; Maehr H; Kong AN; Suh N
Cancer Prev Res (Phila); 2020 Aug; 13(8):673-686. PubMed ID: 32467291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
